 | • レポートコード：MRC2-11QY10930 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は自己免疫疾患診断のグローバル市場について調査・分析したレポートです。種類別（分析装置、アッセイキット）市場規模、用途別（病院、診断研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別自己免疫疾患診断の競争状況、市場シェア ・世界の自己免疫疾患診断市場：種類別市場規模 2015年-2020年（分析装置、アッセイキット） ・世界の自己免疫疾患診断市場：種類別市場規模予測 2021年-2026年（分析装置、アッセイキット） ・世界の自己免疫疾患診断市場：用途別市場規模 2015年-2020年（病院、診断研究所） ・世界の自己免疫疾患診断市場：用途別市場規模予測 2021年-2026年（病院、診断研究所） ・北米の自己免疫疾患診断市場分析：米国、カナダ ・ヨーロッパの自己免疫疾患診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの自己免疫疾患診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の自己免疫疾患診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの自己免疫疾患診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Beckman Coulter、Bio-Rad Laboratories、EUROIMMUN、Inova Diagnostics、Roche Diagnostics、Siemens Healthcare、DiaSorin、ERBA Diagnostics、Euro Diagnostica、Autoimmune Technologies、Avant Diagnostics、Exagen Diagnostics、Gold Standard Diagnostics、HOB Diagnostics、HUMAN Diagnostics、Immco Diagnostics、ImmunArray、Myriad Genetics、Omega Diagnostics、ORGENTEC Diagnostika、Phadia、Protagen ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The diagnosis of autoimmune diseases depends on the identification of disease-associated clinical symptoms and is associated with the detection of autoantibodies. Clinicians conventionally classify autoimmune diseases as either systemic or organ-specific.
In terms of geography, the Americas led the global autoimmune disease diagnostics market and will continue to dominate the market in the coming years. The growing incidence of autoimmune disorders such as RA, SLE, and IBD will aid in the growth of this market. Also, the extensive R&D activities has allowed the launch of novel diagnostic products, which are expected to drive the adoption rates for autoimmune diagnostics in the Americas.
Market Analysis and Insights: Global Autoimmune Disease Diagnostics Market
The global Autoimmune Disease Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Autoimmune Disease Diagnostics Scope and Market Size
Autoimmune Disease Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Autoimmune Disease Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
EUROIMMUN
Inova Diagnostics
Roche Diagnostics
Siemens Healthcare
DiaSorin
ERBA Diagnostics
Euro Diagnostica
Autoimmune Technologies
Avant Diagnostics
Exagen Diagnostics
Gold Standard Diagnostics
HOB Diagnostics
HUMAN Diagnostics
Immco Diagnostics
ImmunArray
Myriad Genetics
Omega Diagnostics
ORGENTEC Diagnostika
Phadia
Protagen
Market segment by Type, the product can be split into
Analyzers
Assay Kits
Market segment by Application, split into
Hospitals
Diagnostic and Research Laboratories
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Autoimmune Disease Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Autoimmune Disease Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Analyzers
1.4.3 Assay Kits
1.5 Market by Application
1.5.1 Global Autoimmune Disease Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostic and Research Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Disease Diagnostics Market Perspective (2015-2026)
2.2 Global Autoimmune Disease Diagnostics Growth Trends by Regions
2.2.1 Autoimmune Disease Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Autoimmune Disease Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Autoimmune Disease Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Autoimmune Disease Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Autoimmune Disease Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Disease Diagnostics Players by Market Size
3.1.1 Global Top Autoimmune Disease Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Autoimmune Disease Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Autoimmune Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Autoimmune Disease Diagnostics Market Concentration Ratio
3.2.1 Global Autoimmune Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Diagnostics Revenue in 2019
3.3 Autoimmune Disease Diagnostics Key Players Head office and Area Served
3.4 Key Players Autoimmune Disease Diagnostics Product Solution and Service
3.5 Date of Enter into Autoimmune Disease Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Autoimmune Disease Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Autoimmune Disease Diagnostics Market Size by Application (2015-2020)
5.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Autoimmune Disease Diagnostics Market Size (2015-2020)
6.2 Autoimmune Disease Diagnostics Key Players in North America (2019-2020)
6.3 North America Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
6.4 North America Autoimmune Disease Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Autoimmune Disease Diagnostics Market Size (2015-2020)
7.2 Autoimmune Disease Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
7.4 Europe Autoimmune Disease Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Autoimmune Disease Diagnostics Market Size (2015-2020)
8.2 Autoimmune Disease Diagnostics Key Players in China (2019-2020)
8.3 China Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
8.4 China Autoimmune Disease Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Autoimmune Disease Diagnostics Market Size (2015-2020)
9.2 Autoimmune Disease Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
9.4 Japan Autoimmune Disease Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Autoimmune Disease Diagnostics Market Size (2015-2020)
10.2 Autoimmune Disease Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Autoimmune Disease Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Autoimmune Disease Diagnostics Market Size (2015-2020)
11.2 Autoimmune Disease Diagnostics Key Players in India (2019-2020)
11.3 India Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
11.4 India Autoimmune Disease Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Autoimmune Disease Diagnostics Market Size (2015-2020)
12.2 Autoimmune Disease Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Autoimmune Disease Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Autoimmune Disease Diagnostics Introduction
13.1.4 Abbott Laboratories Revenue in Autoimmune Disease Diagnostics Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Beckman Coulter
13.2.1 Beckman Coulter Company Details
13.2.2 Beckman Coulter Business Overview
13.2.3 Beckman Coulter Autoimmune Disease Diagnostics Introduction
13.2.4 Beckman Coulter Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
13.2.5 Beckman Coulter Recent Development
13.3 Bio-Rad Laboratories
13.3.1 Bio-Rad Laboratories Company Details
13.3.2 Bio-Rad Laboratories Business Overview
13.3.3 Bio-Rad Laboratories Autoimmune Disease Diagnostics Introduction
13.3.4 Bio-Rad Laboratories Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
13.3.5 Bio-Rad Laboratories Recent Development
13.4 EUROIMMUN
13.4.1 EUROIMMUN Company Details
13.4.2 EUROIMMUN Business Overview
13.4.3 EUROIMMUN Autoimmune Disease Diagnostics Introduction
13.4.4 EUROIMMUN Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
13.4.5 EUROIMMUN Recent Development
13.5 Inova Diagnostics
13.5.1 Inova Diagnostics Company Details
13.5.2 Inova Diagnostics Business Overview
13.5.3 Inova Diagnostics Autoimmune Disease Diagnostics Introduction
13.5.4 Inova Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
13.5.5 Inova Diagnostics Recent Development
13.6 Roche Diagnostics
13.6.1 Roche Diagnostics Company Details
13.6.2 Roche Diagnostics Business Overview
13.6.3 Roche Diagnostics Autoimmune Disease Diagnostics Introduction
13.6.4 Roche Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
13.6.5 Roche Diagnostics Recent Development
13.7 Siemens Healthcare
13.7.1 Siemens Healthcare Company Details
13.7.2 Siemens Healthcare Business Overview
13.7.3 Siemens Healthcare Autoimmune Disease Diagnostics Introduction
13.7.4 Siemens Healthcare Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
13.7.5 Siemens Healthcare Recent Development
13.8 DiaSorin
13.8.1 DiaSorin Company Details
13.8.2 DiaSorin Business Overview
13.8.3 DiaSorin Autoimmune Disease Diagnostics Introduction
13.8.4 DiaSorin Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
13.8.5 DiaSorin Recent Development
13.9 ERBA Diagnostics
13.9.1 ERBA Diagnostics Company Details
13.9.2 ERBA Diagnostics Business Overview
13.9.3 ERBA Diagnostics Autoimmune Disease Diagnostics Introduction
13.9.4 ERBA Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
13.9.5 ERBA Diagnostics Recent Development
13.10 Euro Diagnostica
13.10.1 Euro Diagnostica Company Details
13.10.2 Euro Diagnostica Business Overview
13.10.3 Euro Diagnostica Autoimmune Disease Diagnostics Introduction
13.10.4 Euro Diagnostica Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
13.10.5 Euro Diagnostica Recent Development
13.11 Autoimmune Technologies
10.11.1 Autoimmune Technologies Company Details
10.11.2 Autoimmune Technologies Business Overview
10.11.3 Autoimmune Technologies Autoimmune Disease Diagnostics Introduction
10.11.4 Autoimmune Technologies Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.11.5 Autoimmune Technologies Recent Development
13.12 Avant Diagnostics
10.12.1 Avant Diagnostics Company Details
10.12.2 Avant Diagnostics Business Overview
10.12.3 Avant Diagnostics Autoimmune Disease Diagnostics Introduction
10.12.4 Avant Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.12.5 Avant Diagnostics Recent Development
13.13 Exagen Diagnostics
10.13.1 Exagen Diagnostics Company Details
10.13.2 Exagen Diagnostics Business Overview
10.13.3 Exagen Diagnostics Autoimmune Disease Diagnostics Introduction
10.13.4 Exagen Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.13.5 Exagen Diagnostics Recent Development
13.14 Gold Standard Diagnostics
10.14.1 Gold Standard Diagnostics Company Details
10.14.2 Gold Standard Diagnostics Business Overview
10.14.3 Gold Standard Diagnostics Autoimmune Disease Diagnostics Introduction
10.14.4 Gold Standard Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.14.5 Gold Standard Diagnostics Recent Development
13.15 HOB Diagnostics
10.15.1 HOB Diagnostics Company Details
10.15.2 HOB Diagnostics Business Overview
10.15.3 HOB Diagnostics Autoimmune Disease Diagnostics Introduction
10.15.4 HOB Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.15.5 HOB Diagnostics Recent Development
13.16 HUMAN Diagnostics
10.16.1 HUMAN Diagnostics Company Details
10.16.2 HUMAN Diagnostics Business Overview
10.16.3 HUMAN Diagnostics Autoimmune Disease Diagnostics Introduction
10.16.4 HUMAN Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.16.5 HUMAN Diagnostics Recent Development
13.17 Immco Diagnostics
10.17.1 Immco Diagnostics Company Details
10.17.2 Immco Diagnostics Business Overview
10.17.3 Immco Diagnostics Autoimmune Disease Diagnostics Introduction
10.17.4 Immco Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.17.5 Immco Diagnostics Recent Development
13.18 ImmunArray
10.18.1 ImmunArray Company Details
10.18.2 ImmunArray Business Overview
10.18.3 ImmunArray Autoimmune Disease Diagnostics Introduction
10.18.4 ImmunArray Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.18.5 ImmunArray Recent Development
13.19 Myriad Genetics
10.19.1 Myriad Genetics Company Details
10.19.2 Myriad Genetics Business Overview
10.19.3 Myriad Genetics Autoimmune Disease Diagnostics Introduction
10.19.4 Myriad Genetics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.19.5 Myriad Genetics Recent Development
13.20 Omega Diagnostics
10.20.1 Omega Diagnostics Company Details
10.20.2 Omega Diagnostics Business Overview
10.20.3 Omega Diagnostics Autoimmune Disease Diagnostics Introduction
10.20.4 Omega Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.20.5 Omega Diagnostics Recent Development
13.21 ORGENTEC Diagnostika
10.21.1 ORGENTEC Diagnostika Company Details
10.21.2 ORGENTEC Diagnostika Business Overview
10.21.3 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Introduction
10.21.4 ORGENTEC Diagnostika Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.21.5 ORGENTEC Diagnostika Recent Development
13.22 Phadia
10.22.1 Phadia Company Details
10.22.2 Phadia Business Overview
10.22.3 Phadia Autoimmune Disease Diagnostics Introduction
10.22.4 Phadia Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.22.5 Phadia Recent Development
13.23 Protagen
10.23.1 Protagen Company Details
10.23.2 Protagen Business Overview
10.23.3 Protagen Autoimmune Disease Diagnostics Introduction
10.23.4 Protagen Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
10.23.5 Protagen Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Autoimmune Disease Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Autoimmune Disease Diagnostics Revenue
Table 3. Ranking of Global Top Autoimmune Disease Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Autoimmune Disease Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Analyzers
Table 6. Key Players of Assay Kits
Table 7. Global Autoimmune Disease Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Autoimmune Disease Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Autoimmune Disease Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Autoimmune Disease Diagnostics Market Share by Regions (2015-2020)
Table 11. Global Autoimmune Disease Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Autoimmune Disease Diagnostics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Autoimmune Disease Diagnostics Market Growth Strategy
Table 17. Main Points Interviewed from Key Autoimmune Disease Diagnostics Players
Table 18. Global Autoimmune Disease Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Autoimmune Disease Diagnostics Market Share by Players (2015-2020)
Table 20. Global Top Autoimmune Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Diagnostics as of 2019)
Table 21. Global Autoimmune Disease Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Autoimmune Disease Diagnostics Product Solution and Service
Table 24. Date of Enter into Autoimmune Disease Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Autoimmune Disease Diagnostics Market Size Share by Type (2015-2020)
Table 28. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2021-2026)
Table 29. Global Autoimmune Disease Diagnostics Market Size Share by Application (2015-2020)
Table 30. Global Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Autoimmune Disease Diagnostics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Autoimmune Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Autoimmune Disease Diagnostics Market Share (2019-2020)
Table 34. North America Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Autoimmune Disease Diagnostics Market Share by Type (2015-2020)
Table 36. North America Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Autoimmune Disease Diagnostics Market Share by Application (2015-2020)
Table 38. Europe Key Players Autoimmune Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Autoimmune Disease Diagnostics Market Share (2019-2020)
Table 40. Europe Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Autoimmune Disease Diagnostics Market Share by Type (2015-2020)
Table 42. Europe Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Autoimmune Disease Diagnostics Market Share by Application (2015-2020)
Table 44. China Key Players Autoimmune Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Autoimmune Disease Diagnostics Market Share (2019-2020)
Table 46. China Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 47. China Autoimmune Disease Diagnostics Market Share by Type (2015-2020)
Table 48. China Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 49. China Autoimmune Disease Diagnostics Market Share by Application (2015-2020)
Table 50. Japan Key Players Autoimmune Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Autoimmune Disease Diagnostics Market Share (2019-2020)
Table 52. Japan Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Autoimmune Disease Diagnostics Market Share by Type (2015-2020)
Table 54. Japan Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Autoimmune Disease Diagnostics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Autoimmune Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Autoimmune Disease Diagnostics Market Share (2019-2020)
Table 58. Southeast Asia Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Autoimmune Disease Diagnostics Market Share by Type (2015-2020)
Table 60. Southeast Asia Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Autoimmune Disease Diagnostics Market Share by Application (2015-2020)
Table 62. India Key Players Autoimmune Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Autoimmune Disease Diagnostics Market Share (2019-2020)
Table 64. India Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 65. India Autoimmune Disease Diagnostics Market Share by Type (2015-2020)
Table 66. India Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 67. India Autoimmune Disease Diagnostics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Autoimmune Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Autoimmune Disease Diagnostics Market Share (2019-2020)
Table 70. Central & South America Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Autoimmune Disease Diagnostics Market Share by Type (2015-2020)
Table 72. Central & South America Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Autoimmune Disease Diagnostics Market Share by Application (2015-2020)
Table 74. Abbott Laboratories Company Details
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories Product
Table 77. Abbott Laboratories Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 78. Abbott Laboratories Recent Development
Table 79. Beckman Coulter Company Details
Table 80. Beckman Coulter Business Overview
Table 81. Beckman Coulter Product
Table 82. Beckman Coulter Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 83. Beckman Coulter Recent Development
Table 84. Bio-Rad Laboratories Company Details
Table 85. Bio-Rad Laboratories Business Overview
Table 86. Bio-Rad Laboratories Product
Table 87. Bio-Rad Laboratories Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 88. Bio-Rad Laboratories Recent Development
Table 89. EUROIMMUN Company Details
Table 90. EUROIMMUN Business Overview
Table 91. EUROIMMUN Product
Table 92. EUROIMMUN Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 93. EUROIMMUN Recent Development
Table 94. Inova Diagnostics Company Details
Table 95. Inova Diagnostics Business Overview
Table 96. Inova Diagnostics Product
Table 97. Inova Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 98. Inova Diagnostics Recent Development
Table 99. Roche Diagnostics Company Details
Table 100. Roche Diagnostics Business Overview
Table 101. Roche Diagnostics Product
Table 102. Roche Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 103. Roche Diagnostics Recent Development
Table 104. Siemens Healthcare Company Details
Table 105. Siemens Healthcare Business Overview
Table 106. Siemens Healthcare Product
Table 107. Siemens Healthcare Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 108. Siemens Healthcare Recent Development
Table 109. DiaSorin Business Overview
Table 110. DiaSorin Product
Table 111. DiaSorin Company Details
Table 112. DiaSorin Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 113. DiaSorin Recent Development
Table 114. ERBA Diagnostics Company Details
Table 115. ERBA Diagnostics Business Overview
Table 116. ERBA Diagnostics Product
Table 117. ERBA Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 118. ERBA Diagnostics Recent Development
Table 119. Euro Diagnostica Company Details
Table 120. Euro Diagnostica Business Overview
Table 121. Euro Diagnostica Product
Table 122. Euro Diagnostica Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 123. Euro Diagnostica Recent Development
Table 124. Autoimmune Technologies Company Details
Table 125. Autoimmune Technologies Business Overview
Table 126. Autoimmune Technologies Product
Table 127. Autoimmune Technologies Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 128. Autoimmune Technologies Recent Development
Table 129. Avant Diagnostics Company Details
Table 130. Avant Diagnostics Business Overview
Table 131. Avant Diagnostics Product
Table 132. Avant Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 133. Avant Diagnostics Recent Development
Table 134. Exagen Diagnostics Company Details
Table 135. Exagen Diagnostics Business Overview
Table 136. Exagen Diagnostics Product
Table 137. Exagen Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 138. Exagen Diagnostics Recent Development
Table 139. Gold Standard Diagnostics Company Details
Table 140. Gold Standard Diagnostics Business Overview
Table 141. Gold Standard Diagnostics Product
Table 142. Gold Standard Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 143. Gold Standard Diagnostics Recent Development
Table 144. HOB Diagnostics Company Details
Table 145. HOB Diagnostics Business Overview
Table 146. HOB Diagnostics Product
Table 147. HOB Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 148. HOB Diagnostics Recent Development
Table 149. HUMAN Diagnostics Company Details
Table 150. HUMAN Diagnostics Business Overview
Table 151. HUMAN Diagnostics Product
Table 152. HUMAN Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 153. HUMAN Diagnostics Recent Development
Table 154. Immco Diagnostics Company Details
Table 155. Immco Diagnostics Business Overview
Table 156. Immco Diagnostics Product
Table 157. Immco Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 158. Immco Diagnostics Recent Development
Table 159. ImmunArray Company Details
Table 160. ImmunArray Business Overview
Table 161. ImmunArray Product
Table 162. ImmunArray Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 163. ImmunArray Recent Development
Table 164. Myriad Genetics Company Details
Table 165. Myriad Genetics Business Overview
Table 166. Myriad Genetics Product
Table 167. Myriad Genetics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 168. Myriad Genetics Recent Development
Table 169. Omega Diagnostics Company Details
Table 170. Omega Diagnostics Business Overview
Table 171. Omega Diagnostics Product
Table 172. Omega Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 173. Omega Diagnostics Recent Development
Table 174. ORGENTEC Diagnostika Company Details
Table 175. ORGENTEC Diagnostika Business Overview
Table 176. ORGENTEC Diagnostika Product
Table 177. ORGENTEC Diagnostika Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 178. ORGENTEC Diagnostika Recent Development
Table 179. Phadia Company Details
Table 180. Phadia Business Overview
Table 181. Phadia Product
Table 182. Phadia Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 183. Phadia Recent Development
Table 184. Protagen Company Details
Table 185. Protagen Business Overview
Table 186. Protagen Product
Table 187. Protagen Revenue in Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 188. Protagen Recent Development
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Disease Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Analyzers Features
Figure 3. Assay Kits Features
Figure 4. Global Autoimmune Disease Diagnostics Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Diagnostic and Research Laboratories Case Studies
Figure 7. Autoimmune Disease Diagnostics Report Years Considered
Figure 8. Global Autoimmune Disease Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Autoimmune Disease Diagnostics Market Share by Regions: 2020 VS 2026
Figure 10. Global Autoimmune Disease Diagnostics Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Autoimmune Disease Diagnostics Market Share by Players in 2019
Figure 13. Global Top Autoimmune Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Diagnostics as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Autoimmune Disease Diagnostics Revenue in 2019
Figure 15. North America Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
自己免疫疾患用体外診断（IVD）・ラボ開発検査の世界市場（～2026年） In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases. The market growth is attributed to rising occurren…- ライム病診断の世界市場（～2026年） Market Analysis and Insights: Global Lyme Disease Diagnostics Market The global Lyme Disease Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Lyme Disease Diagnostics Scope and Market Size Lyme Disease Diagn…
- ポイントオブケア感染症診断の世界市場（～2026年） Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment. The point-of-care infectious disease diagnostics market is expected to register a fast growth over the forecast period owing to the emerging trend of patient-centric se…
- 呼吸器疾患検査/診断の世界市場（～2026年） Respiratory measuring devices, also known as respirometers, include respirometers, pulse oximeters, carbonic acid meters, and peak flow meters. The prevalence of respiratory diseases such as chronic obstructive pulmonary disease, asthma and other respiratory infections, as well as the increasing pop…
- 感染症診断検査の世界市場（～2026年） Market Analysis and Insights: Global Infectious Disease Diagnostic Testing Market The global Infectious Disease Diagnostic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Infectious Disease Diagnostic Testing S…